Citadel Advisors’s Omega Healthcare OHI Stock Holding History

Citadel Advisors’s Portfolio OHI Stock Details OHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.89M	Sell	111,600 -31,200	-22%	-$1.42M	﹤0.01%	4371
2025 Q4	$6.33M	Sell	142,800 -423,200	-75%	-$18.2M	﹤0.01%	3920
2025 Q3	$23.9M	Buy	566,000 +428,900	+313%	+$17.3M	﹤0.01%	2112
2025 Q2	$5.02M	Sell	137,100 -55,300	-29%	-$2.05M	﹤0.01%	4109
2025 Q1	$7.33M	Sell	192,400 -700	-0.4%	-$26K	﹤0.01%	3304
2024 Q4	$7.31M	Sell	193,100 -75,200	-28%	-$3.01M	﹤0.01%	3383
2024 Q3	$10.9M	Sell	268,300 -41,000	-13%	-$1.55M	﹤0.01%	2765
2024 Q2	$10.6M	Sell	309,300 -96,400	-24%	-$3.04M	﹤0.01%	2699
2024 Q1	$12.8M	Buy	405,700 +52,400	+15%	+$1.59M	﹤0.01%	2603
2023 Q4	$10.8M	Sell	353,300 -105,200	-23%	-$3.38M	﹤0.01%	2732
2023 Q3	$15.2M	Buy	458,500 +16,900	+4%	+$540K	﹤0.01%	2177
2023 Q2	$13.6M	Sell	441,600 -121,000	-22%	-$3.5M	﹤0.01%	2300
2023 Q1	$15.4M	Sell	562,600 -197,200	-26%	-$5.49M	﹤0.01%	2234
2022 Q4	$21.2M	Sell	759,800 -43,500	-5%	-$1.31M	0.01%	1911
2022 Q3	$23.7M	Buy	803,300 +257,000	+47%	+$8.06M	0.01%	1714
2022 Q2	$15.4M	Buy	546,300 +228,900	+72%	+$6.51M	﹤0.01%	2131
2022 Q1	$9.89M	Sell	317,400 -58,000	-15%	-$1.71M	﹤0.01%	2983
2021 Q4	$11.1M	Buy	375,400 +127,300	+51%	+$3.72M	﹤0.01%	2900
2021 Q3	$7.43M	Buy	248,100 +81,900	+49%	+$2.82M	﹤0.01%	3586
2021 Q2	$6.03M	Buy	166,200 +5,100	+3%	+$189K	﹤0.01%	4055
2021 Q1	$5.9M	Buy	161,100 +2,600	+2%	+$95.7K	﹤0.01%	3905
2020 Q4	$5.76M	Sell	158,500 -23,300	-13%	-$790K	﹤0.01%	3450
2020 Q3	$5.44M	Buy	181,800 +19,700	+12%	+$615K	﹤0.01%	3026
2020 Q2	$4.82M	Sell	162,100 -15,300	-9%	-$453K	﹤0.01%	3136
2020 Q1	$4.71M	Sell	177,400 -51,500	-22%	-$1.95M	﹤0.01%	2789
2019 Q4	$9.69M	Sell	228,900 -36,600	-14%	-$1.55M	﹤0.01%	2240
2019 Q3	$11.1M	Buy	265,500 +78,600	+42%	+$3.06M	0.01%	2095
2019 Q2	$6.87M	Buy	186,900 +7,700	+4%	+$281K	﹤0.01%	2652
2019 Q1	$6.84M	Buy	179,200 +7,600	+4%	+$282K	﹤0.01%	2552
2018 Q4	$6.03M	Sell	171,600 -8,600	-5%	-$298K	﹤0.01%	2530
2018 Q3	$5.91M	Sell	180,200 -39,800	-18%	-$1.27M	﹤0.01%	2777
2018 Q2	$6.82M	Buy	220,000 +80,400	+58%	+$2.3M	﹤0.01%	2378
2018 Q1	$3.77M	Buy	139,600 +63,100	+82%	+$1.68M	﹤0.01%	2819
2017 Q4	$2.11M	Sell	76,500 -10,800	-12%	-$312K	﹤0.01%	3566
2017 Q3	$2.79M	Buy	87,300 +35,700	+69%	+$1.14M	﹤0.01%	3013
2017 Q2	$1.7M	Buy	51,600 +44,300	+607%	+$1.47M	﹤0.01%	3380
2017 Q1	$241K	Sell	7,300 -9,400	-56%	-$302K	﹤0.01%	6218
2016 Q4	$522K	Sell	16,700 -39,600	-70%	-$1.22M	﹤0.01%	4829
2016 Q3	$2M	Buy	56,300 +39,700	+239%	+$1.41M	﹤0.01%	2971
2016 Q2	$564K	Sell	16,600 -18,400	-53%	-$614K	﹤0.01%	4321
2016 Q1	$1.24M	Buy	35,000 +16,900	+93%	+$553K	﹤0.01%	3220
2015 Q4	$633K	Sell	18,100 -1,700	-9%	-$58.7K	﹤0.01%	4162
2015 Q3	$696K	Buy	19,800 +6,600	+50%	+$232K	﹤0.01%	4311
2015 Q2	$453K	Buy	13,200 +2,500	+23%	+$91.8K	﹤0.01%	5139
2015 Q1	$434K	Buy	10,700 +2,700	+34%	+$112K	﹤0.01%	5125
2014 Q4	$313K	Sell	8,000 -8,700	-52%	-$330K	﹤0.01%	5366
2014 Q3	$571K	Sell	16,700 -3,400	-17%	-$125K	﹤0.01%	4435
2014 Q2	$741K	Buy	20,100 +10,700	+114%	+$382K	﹤0.01%	3879
2014 Q1	$315K	Buy	9,400 +4,400	+88%	+$140K	﹤0.01%	4966
2013 Q4	$149K	Sell	5,000 -18,600	-79%	-$589K	﹤0.01%	5292
2013 Q3	$705K	Sell	23,600 -8,900	-27%	-$271K	﹤0.01%	3453
2013 Q2	$1.01M	Buy	+32,500	New	+$1.07M	﹤0.01%	3184

Other funds holding OHI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors's OHI Position: Q1 2026 in Review

Citadel Advisors sold out of Omega Healthcare (OHI) in Q1 2026, closing a stake of 135,153 shares — an estimated $6.17M sold.

Citadel Advisors first reported a position in OHI in Q2 2013 and held it in 47 quarters. The position peaked at $52.8M in Q1 2017. 743 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

Citadel Advisors reported no remaining Omega Healthcare position as of Q1 2026 after selling out during the quarter.
Citadel Advisors sold 135,153 Omega Healthcare shares in Q1 2026, an estimated $6.17M.
Citadel Advisors first reported a position in Omega Healthcare in Q2 2013 and held it in 47 quarters.
Citadel Advisors's Omega Healthcare position peaked at $52.8M in Q1 2017.
743 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.